Skip to search formSkip to main contentSkip to account menu

Glycogen Storage Disease Type III

Known as: GDE DEFICIENCY, Glycogenosis 3s, LIMIT DEXTRINOSIS 
An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Objective: Glycogen storage disease type IIIa (GSDIIIa) is classically regarded as a glycogenosis with fixed weakness, but we… 
2005
2005
SummaryTo identify the severity of cardiac involvement in glycogen storage disease type III (GSDIII), and its relation to… 
Highly Cited
2004
Highly Cited
2004
ABSTRACT The yeast Snf1 kinase and its mammalian ortholog, AMP-activated protein kinase (AMPK), regulate responses to metabolic… 
2002
2002
AbstractGlycogen storage disease type III (GSD III) is a rare autosomal recessive inherited disorder caused by a deficiency of… 
Highly Cited
1996
Highly Cited
1996
Glycogen debranching enzyme (gene symbol, AGL) is a multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4… 
1989
1989
Twenty patients with enzymatically proven glycogen storage disease type III (GSD III) aged 3–30 years underwent cardiological… 
Highly Cited
1942
Highly Cited
1942